Human leukocyte antigen B*0702 is protective against ocular Stevens-Johnson syndrome/toxic epidermal necrolysis in the UK population.

Butt GF, Hassan A, Wallace GR, Kinoshita S, Ahmad S, Ueta M, Rauz S

Open source

DOI
10.1038/s41598-021-82400-3
Published
2021 Feb 3
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-021-82400-3,
  title = {Human leukocyte antigen B*0702 is protective against ocular Stevens-Johnson syndrome/toxic epidermal necrolysis in the UK population.},
  author = {Butt GF and Hassan A and Wallace GR and Kinoshita S and Ahmad S and Ueta M and Rauz S},
  year = {2021},
  journal = {Scientific reports},
  doi = {10.1038/s41598-021-82400-3},
  url = {https://doi.org/10.1038/s41598-021-82400-3}
}

RIS

TY  - JOUR
TI  - Human leukocyte antigen B*0702 is protective against ocular Stevens-Johnson syndrome/toxic epidermal necrolysis in the UK population.
AU  - Butt GF
AU  - Hassan A
AU  - Wallace GR
AU  - Kinoshita S
AU  - Ahmad S
AU  - Ueta M
AU  - Rauz S
PY  - 2021
JO  - Scientific reports
DO  - 10.1038/s41598-021-82400-3
UR  - https://doi.org/10.1038/s41598-021-82400-3
ER  - 

APA

GF, B., A, H., GR, W., S, K., S, A., M, U., & S, R. (2021). Human leukocyte antigen B*0702 is protective against ocular Stevens-Johnson syndrome/toxic epidermal necrolysis in the UK population.. Scientific reports. https://doi.org/10.1038/s41598-021-82400-3

Source records